Senior insider sale
Chief Financial Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$84.2K
3.12K shares
What this filing means
GRUBER JAMES R. plans to sell 3.12K shares of ETON PHARMACEUTICALS, INC. valued at approximately $84.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/2/2026ACC: 0001974078-26-000212
Officer· Chief Financial Officer
Since Apr 2022
3.12K
Shares to sell
$84.2K
Approx. market value
3.12K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU
CASH
6/1/2026
3.12KTotal acquired3.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/1/2026 | RSU CASH | 3.12K | — |
| Total | 3.12K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.12K
Market value
$84.2K
6/2/2026
Total
Units
3.12K
Value
$84.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/2/2026 | 3.12K | $84.2K | NASDAQ | Planned |
| Total | 3.12K | $84.2K | ||